Applicable advances in the molecular pathology of glioblastoma.

作者: Melissa Ranjit , Kazuya Motomura , Fumiharu Ohka , Toshihiko Wakabayashi , Atsushi Natsume

DOI: 10.1007/S10014-015-0224-6

关键词:

摘要: Comprising more than 80% of malignant brain tumors, glioma has proven to be a daunting cause mortality in vast majority the human population. Progressive and extensive research on substantially enhanced our understanding cell biology molecular pathology. Subtypes such as astrocytoma oligodendroglioma are currently grouped together into one pathological class, where they show many differences histology etiology. This indicates that it may beneficial consider new radical subclassification. Thus, we summarize recent developments glioblastoma multiforme (GBM) subtypes, immunohistochemical analyses useful for diagnoses biological evaluation therapeutic implications gliomas this review.

参考文章(82)
G Reifenberger, K Ichimura, V P Collins, E E Schmidt, CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research. ,vol. 54, pp. 6321- 6324 ,(1994)
Bert Vogelstein, David Lane, Arnold J. Levine, Surfing the p53 network Nature. ,vol. 408, pp. 307- 310 ,(2000) , 10.1038/35042675
W Wechsler, L Liu, L Liu, G Reifenberger, G Reifenberger, J Reifenberger, C D James, V P Collins, V P Collins, Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. American Journal of Pathology. ,vol. 145, pp. 1175- 1190 ,(1994)
Yuchen Jiao, Patrick J. Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, Sergio Rosemberg, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. Lopez, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Diaz, Hai Yan, Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. ,vol. 3, pp. 709- 722 ,(2012) , 10.18632/ONCOTARGET.588
Yukinari Kato, Atsushi Natsume, Mika Kato Kaneko, A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation Biochemical and Biophysical Research Communications. ,vol. 432, pp. 564- 567 ,(2013) , 10.1016/J.BBRC.2013.02.049
Toshihiko Wakabayashi, Atsushi Natsume, Hisashi Hatano, Masazumi Fujii, Shinji Shimato, Motokazu Ito, Masasuke Ohno, Satoshi Ito, Masatoshi Ogura, Jun Yoshida, p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas. Neurosurgery. ,vol. 64, pp. 455- 462 ,(2009) , 10.1227/01.NEU.0000340683.19920.E3
Paul B. Talbert, Steven Henikoff, Histone variants — ancient wrap artists of the epigenome Nature Reviews Molecular Cell Biology. ,vol. 11, pp. 264- 275 ,(2010) , 10.1038/NRM2861
Hideyuki Arita, Yoshitaka Narita, Shintaro Fukushima, Kensuke Tateishi, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, V. Peter Collins, Nobutaka Kawahara, Soichiro Shibui, Koichi Ichimura, Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss Acta Neuropathologica. ,vol. 126, pp. 267- 276 ,(2013) , 10.1007/S00401-013-1141-6
Towia A. Libermann, Harris R. Nusbaum, Nissim Razon, Richard Kris, Irit Lax, Hermona Soreq, Nigel Whittle, Michael D. Waterfield, Axel Ullrich, Joseph Schlessinger, Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin Nature. ,vol. 313, pp. 144- 147 ,(1985) , 10.1038/313144A0
Jörg Felsberg, Niklas Thon, Sabina Eigenbrod, Bettina Hentschel, Michael C. Sabel, Manfred Westphal, Gabriele Schackert, Friedrich Wilhelm Kreth, Torsten Pietsch, Markus Löffler, Michael Weller, Guido Reifenberger, Jörg C. Tonn, , Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas International Journal of Cancer. ,vol. 129, pp. 659- 670 ,(2011) , 10.1002/IJC.26083